Your browser doesn't support javascript.
loading
Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model.
Lee, Wei-Chia; Tain, You-Lin; Chuang, Yao-Chi; Tsai, Cheng-Nan; Yu, Chun-Chieh; Su, Chia-Hao.
Afiliação
  • Lee WC; Division of Urology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.
  • Tain YL; Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.
  • Chuang YC; Division of Urology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.
  • Tsai CN; Division of Urology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.
  • Yu CC; Center for Shock Wave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, ROC.
  • Su CH; Division of Urology, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.
Neurourol Urodyn ; 38(8): 2159-2169, 2019 11.
Article em En | MEDLINE | ID: mdl-31541501
ABSTRACT

AIM:

We investigated the effects of Ba-Wei-Die-Huang-Wan (BWDHW) on ketamine-induced cystitis (KIC) in a rat model.

METHODS:

Female Sprague-Dawley rats were distributed into three groups control (saline), ketamine (25 mg/kg/day for 28 days), or ketamine (25 mg/kg/day for 28 days) plus BWDHW (90 mg/kg/day, started from day 14). Functional magnetic resonance imaging (fMRI), metabolic cage study, and cystometry were evaluated. Bladder histology was evaluated. Western blots of the bladder proteins were carried out.

RESULTS:

Compared with controls, ketamine-treated rats showed stronger fMRI intensity in the periaqueductal gray area and bladder overactivity in the bladder functional study, but the ketamine/BWDHW-treated rats did not. Furthermore, ketamine breached the uroplakin III membrane at the apical surface of the urothelium, enhanced substance P spread over the urothelium, induced suburothelial hemorrhage and monocyte/macrophage infiltration, and caused interstitial fibrosis deposition. By contrast, the BWDHW-treated rats exhibited less substance P spread, lower suburothelial monocyte/macrophage infiltration, and lower interstitial fibrosis deposition. The ketamine group showed significant overexpression of neuroreceptors in the bladder mucosa (the transient receptor potential vanilloid 1 and M2 - and M3 -muscarinic receptors) and detrusor (M2 - and M3 -muscarinic receptors); inflammatory mediators in the detrusor (interleukin-1ß [IL-1ß], IL-6, tumor necrosis factor-α, nuclear factor-κB, cyclooxygenase-2, and intercellular adhesion molecule-1); and fibrogenesis molecules in the detrusor (transforming growth factor-ß1, collagen I, collagen III, and fibronectin). However, no significant changes were noted between the ketamine/BWDHW and control groups.

CONCLUSION:

BWDHW could exert therapeutic effects by inhibiting the upregulation of neuroreceptors, modulating inflammatory mediators, suppressing fibrogenesis, and ameliorating bladder overactivity in rats with KIC.
Assuntos
Cistite/induzido quimicamente; Medicamentos de Ervas Chinesas/farmacologia; Ketamina/efeitos adversos; Bexiga Urinária Hiperativa/induzido quimicamente; Bexiga Urinária/efeitos dos fármacos; Urotélio/efeitos dos fármacos; Animais; Colágeno/efeitos dos fármacos; Colágeno/metabolismo; Ciclo-Oxigenase 2/efeitos dos fármacos; Ciclo-Oxigenase 2/metabolismo; Cistite/metabolismo; Cistite/patologia; Cistite/fisiopatologia; Feminino; Fibronectinas/efeitos dos fármacos; Fibronectinas/metabolismo; Neuroimagem Funcional; Molécula 1 de Adesão Intercelular/efeitos dos fármacos; Molécula 1 de Adesão Intercelular/metabolismo; Interleucina-1beta/efeitos dos fármacos; Interleucina-1beta/metabolismo; Interleucina-6/metabolismo; Imageamento por Ressonância Magnética; NF-kappa B/efeitos dos fármacos; NF-kappa B/metabolismo; Substância Cinzenta Periaquedutal/diagnóstico por imagem; Ratos; Ratos Sprague-Dawley; Receptores Muscarínicos/efeitos dos fármacos; Receptores Muscarínicos/metabolismo; Células Receptoras Sensoriais; Substância P/efeitos dos fármacos; Substância P/metabolismo; Canais de Cátion TRPV/efeitos dos fármacos; Canais de Cátion TRPV/metabolismo; Fator de Crescimento Transformador beta1/efeitos dos fármacos; Fator de Crescimento Transformador beta1/metabolismo; Fator de Necrose Tumoral alfa/efeitos dos fármacos; Fator de Necrose Tumoral alfa/metabolismo; Bexiga Urinária/metabolismo; Bexiga Urinária/patologia; Bexiga Urinária/fisiopatologia; Bexiga Urinária Hiperativa/metabolismo; Bexiga Urinária Hiperativa/patologia; Bexiga Urinária Hiperativa/fisiopatologia; Urotélio/metabolismo
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bexiga Urinária / Medicamentos de Ervas Chinesas / Urotélio / Cistite / Bexiga Urinária Hiperativa / Ketamina Tipo de estudo: Prognostic_studies Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bexiga Urinária / Medicamentos de Ervas Chinesas / Urotélio / Cistite / Bexiga Urinária Hiperativa / Ketamina Tipo de estudo: Prognostic_studies Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2019 Tipo de documento: Article